Mesenchymal stem cell and gene therapies for spinal fusion

Neurosurgery

Volumn 63, Issue 3, 2008, Pages 380-391

  Gottfried, Oren N ^a   Dailey, Andrew T ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenetic protein; Gene therapy; Mesenchymal stem cells; Osteogenesis; Spinal fusion

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 9; LIPOSOME; NAKED DNA; OSTEOGENIC PROTEIN 1;

BONE CONDUCTION; BONE DEVELOPMENT; BONE GRAFT; BONE GROWTH; BONE MARROW BIOPSY; CELL DIFFERENTIATION; DONOR SITE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HUMAN; IMMUNE RESPONSE; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PLASMID; PRIORITY JOURNAL; REVIEW; SPINE FUSION; TRANSGENE; ANIMAL; CYTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY;

ANIMALS; GENE THERAPY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; SPINAL FUSION;

EID: 65849212897     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000324990.04818.13     Document Type: Review

References (93)

1. Ackerman SJ, Mafilios MS, Polly DW Jr: Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: An evidence-based modeling approach. Spine 27:S94-S99, 2002.
2. Alden TD, Pittman DD, Beres EJ, Hankins GR, Kallmes DF, Wisotsky BM, Kerns KM, Helm GA: Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg 90:109-114, 1999.
3. Alden TD, Varady P, Kallmes DF, Jane JA Jr, Helm GA: Bone morphogenetic protein gene therapy. Spine 27 [Suppl 1]:S87-S93, 2002.
4. Bae H, Badura J, Peckam S, McKay W: Examination of soft tissue edema following implantation of rhBMP-2 on an absorbable collagen sponge in a rat ectopic model. Spine J 7:15S-16S, 2007.
5. Betz VM, Betz OB, Harris MB, Vrahas MS, Evans CH: Bone tissue engineering and repair by gene therapy. Front Biosci 13:833-841, 2008.
6. Betz OB, Betz VM, Nazarian A, Pilapil CG, Vrahas MS, Bouxsein ML, Gerstenfeld LC, Einhorn TA, Evans CH: Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am 88A:355-365, 2006.
7. Boden SD, Schimandle JH: Biologic enhancement of spinal fusion. Spine 20:113S-123S, 1995.
8. Boden S, Kraiwattanapong C, Louis-Ugbo J, Barnes B, Hutton WC: Comparison of Healos/bone marrow to INFUSE(rhBMP-2acs) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 30:1001-1007, 2005.
9. Boden SD, Martin GJ Jr, Morone M, Ugbo JL, Titus L, Hutton WC: The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 24:320-327, 1999.
10. Boden SD, Schimandle JH, Hutton WC: 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine 20:2633-2644, 1995.
11. Boden SD, Titus L, Hair G, Liu Y, Viggeswarapu M, Nanes MS, Baranowski C: Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 23:2486-2492, 1998.
12. Bright C, Park YS, Sieber AN, Kostuik J P, Leong KW: In vivo evaluation of plasmid DNA encoding OP-1 protein for spine fusion. Spine 31:2163-2172, 2006.
13. Bruder S P, Fink DJ, Caplan AI: Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56:283-294, 1994.
14. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S: Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 355 [Suppl]:S247-S256, 1998.
15. Burwell RG: Studies in the transplantation of bone. VII. The fresh composite homograft-autograft of cancellous bone; an analysis of factors leading to osteogenesis in marrow transplants and in marrow-containing bone grafts. J Bone Joint Surg Br 46B:110-140, 1964.
16. Buttermann GR: Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J 8:426-435, 2007.
17. Carlisle E, Fischgrund JS: Bone morphogenetic proteins for spinal fusion. Spine J 5:240S-249S, 2005.
18. Cha CW, Boden SD: Gene therapy applications for spine fusion. Spine 28:S74-S84, 2003.
19. Cinotti G, Patti AM, Vulcano A, Della Rocca C, Polveroni G, Giannicola G, Postacchini F: Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells. J Bone Joint Surg Br 86B:135-142, 2004.
20. Connolly JF: Clinical use of marrow osteoprogenitor cells to stimulate osteo-genesis. Clin Orthop Relat Res 355 [Suppl]:S257-S266, 1998.
21. Cui Q, Ming Xiao Z, Balian G, Wang GJ: Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine 26:2305-2310, 2001.
22. Delawi D, Dhert WJ, Castelein RM, Verbout AJ, Oner FC: The incidence of donor site pain after bone graft harvesting from the posterior iliac crest may be overestimated: A study on spine fracture patients. Spine 32:1865-1868, 2007.
23. Dimar JR, Glassman SD, Burkus KJ, Carreon LY: Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 31:2534-2540, 2006.
24. Dumont RJ, Dayoub H, Li JZ, Dumont AS, Kallmes DF, Hankins GR, Helm GA: Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 51:1239-1245, 2002.
25. Friedenstein AJ, Petrakova K V, Kurolesova AI, Frolova GP: Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230-247, 1968.
26. Gimble JM, Robinson CE, Wu X, Kelly KA: The function of adipocytes in the bone marrow stroma: An update. Bone 19:421-428, 1996.
27. Giordano A, Galderisi U, Marino IR: From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 211:27-35, 2007.
28. Glassman SD, Carreon LY, Campbell MJ, Johnson JR, Puno RM, Djurasovic M, Dimar JR: The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion. Spine J 8:443-448, 2007.
29. Goulet JA, Senunas LE, DeSilva GL, Greenfield ML: Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res 339:76-81, 1997.
30. Gupta MC, Theerajunyaporn T, Maitra S, Schmidt MB, Holy CE, Kadiyala S, Bruder SP: Efficacy of mesenchymal stem cell enriched grafts in an ovine pos-terolateral lumbar spine model. Spine 32:720-727, 2007.
31. Hacker RJ: A randomized prospective study of an anterior cervical interbody fusion device with a minimum of 2 years of follow-up results. J Neurosurg 93:222-226, 2000.
32. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK: Posterior lumbar inter-body fusion using recombinant human bone morphogenetic protein type-2 with cylindrical interbody cages. Spine J 4:527-539, 2004.
33. Halvorsen YC, Wilkison WO, Gimble JM: Adipose-derived stromal cells - Their utility and potential in bone formation. Int J Obes Relat Metab Disord 24 [Suppl 4]:S41-S44, 2000.
34. Hasharoni A, Zilberman Y, Turgeman G, Helm GA, Liebergall M, Gazit D: Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J Neurosurg Spine 3:47-52, 2005.
35. Helm GA, Gazit Z: Future uses of mesenchymal stem cells in spine surgery. Neurosurg Focus 19:E13, 2005.
36. Helm GA, Alden TD, Beres EJ, Hudson SB, Das S, Engh JA, Pittman DD, Kerns KM, Kallmes DF: Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 92:191-196, 2000.
37. Hidaka C, Goshi K, Rawlins B, Boachie-Adjei O, Crystal RG: Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine 28:2049-2057, 2003.
38. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T: Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99:8932-8937, 2002.
39. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP: Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312, 1997.
40. Joseph V, Rampersaud Y: Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion. Spine 32:2885-2890, 2007.
41. Kai T, Shao-qing G, Geng-ting D: In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion. Spine 28:1653-1658, 2003.
42. Khan S, Lane J: Spinal fusion surgery: Animal models for tissue-engineered bone constructs. Biomaterials 25:1475-1485, 2004.
43. Khoueir P, Oh BC, DiRisio DJ, Wang MY: Multilevel anterior cervical fusion using collagen-hydroxyapatite matrix with iliac crest bone marrow aspirate: An 18-month follow-up study. Neurosurgery 61:963-971, 2007.
44. Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, Gazit D: Review: Gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 13:1135-1150, 2007.
45. Kitchel SH, Wang MY, Lauryssen CL: Techniques for aspirating bone marrow for use in spinal surgery. Neurosurgery 57:286-289, 2005.
46. Kraiwattanapong C, Boden SD, Louis-Ugbo J, Attallah E, Barnes B, Hutton WC: Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 30:1001-1007, 2005.
47. Kwon B, Jenis LG: Carrier materials for spinal fusion. Spine J 5:224S-230S, 2005.
48. Laurent JJ, Webb KM, Beres EJ, McGee K, Li J, van Rietbergen B, Helm GA: The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits. J Neurosurg Spine 1:90-94, 2004.
49. Lee TC, Ho JT, Hung KS, Chen WF, Chung YH, Yang YL: Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment. Neurosurgery 58:373-380, 2006.
50. Lewandrowski KU, Nanson C, Calderon R: Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: A report of five cases. Spine J 7:609-614, 2007.
51. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee Y P, Kabo JM, Finerman GA, Berk AJ, Witte ON: The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81A:905-917, 1999.
52. Lu SS, Zhang X, Soo C, Hsu T, Napoli A, Aghaloo T, Wu BM, Tsou P, Ting K, Wang JC: The osteoinductive properties of Nell-1 in a rat spinal fusion model. Spine J 7:50-60, 2007.
53. Ludwig SC, Kowalski JM, Boden SD: Osteoinductive bone graft substitutes. Eur Spine J 9 [Suppl 1]:S119-S125, 2000.
54. Malaval L, Modrowski D, Gupta AK, Aubin JE: Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158:555-572, 1994.
55. McLain RF, Fleming JE, Boehm CA, Muschler GF: Aspiration of osteoprogen-itor cells for augmenting spinal fusion: Comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 87A:2655-2661, 2005.
56. Minamide A, Yoshida M, Kawakami M, Yamasaki S, Kojima H, Hashizume H, Boden SD: The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 30:1134-1138, 2005.
57. Muschler GF, Boehm C, Easley K: Aspiration to obtain osteoblast progenitor cells from human bone marrow: The influence of aspiration volume. J Bone Joint Surg Am 79A:1699-1709, 1997.
58. Muschler GF, Matsukura Y, Nitto H, Boehm CA, Valdevit AD, Kambic HE, Davros WJ, Easley KA, Powell KA: Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop Relat Res 432:242-251, 2005.
59. Muschler GF, Nitto H, Matsukura Y, Boehm C, Valdevit A, Kambic H, Davros W, Powell K, Easley K: Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 407:102-118, 2003.
60. Musgrave DS, Bosch P, Ghivizzani S, Robbins PD, Evans CH, Huard J: Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24:541-547, 1999.
61. Mussano F, Ciccone G, Ceccarelli M, Baldi I, Bassi F: Bone morphogenetic proteins and bone defects: A systematic review. Spine 32:824-830, 2007.
62. Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K: Evaluation of posterolateral spinal fusion using mesenchymal stem cells: Differences with or without osteogenic differentiation. Spine 32:2432-2436, 2007.
63. Neen D, Noyes D, Shaw M, Gwilym S, Fairlie N, Birch N: Healos and bone marrow aspirate used for lumbar spine fusion: A case controlled study comparing Healos with autograft. Spine 31:E636-E640, 2006.
64. Nishida K, Gilbertson LG, Evans CH, Kang JD: Spine update: Potential applications of gene therapy to the treatment of spinal disorders. Spine 25:1308-1314, 2000.
65. Ohgushi H, Dohi Y, Katuda T, Tamai S, Tabata S, Suwa Y: In vitro bone formation by rat marrow cell culture. J Biomed Mater Res 32:333-340, 1996.
66. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146, 2007.
67. Perri B, Cooper M, Lauryssen C, Anand N: Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: A case study. Spine J 7:235-239, 2007.
68. Peterson B, Iglesias R, Zhang J, Wang JC, Lieberman JR: Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: Beyond conventional autologous bone grafting. Spine 30:283-290, 2005.
69. Phillips FM, Bolt PM, He TC, Haydon RC: Gene therapy for spinal fusion. Spine J 5:250S-258S, 2005.
70. Pola E, Gao W, Zhou Y, Pola R, Lattanzi W, Sfeir C, Gambotto A, Robbins PD: Efficient bone formation by gene transfer of human LIM mineralization pro-tein-3. Gene Ther 11:683-693, 2004.
71. Polly DW Jr, Ackerman SJ, Shaffrey CI, Ogilvie JW, Wang JC, Stralka SW, Mafilios MS, Heim SE, Sandhu HS: A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics 26:1027-1037, 2003.
72. Riew KD, Lou J, Wright NM, Cheng SL, Bae KT, Avioli LV: Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique. J Bone Joint Surg Am 85A:866-871, 2003.
73. Riew KD, Wright NM, Cheng S, Avioli LV, Lou J: Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 63:357-360, 1998.
74. Risbud MV, Shapiro IM, Guttapalli A, Di Martino A, Danielson KG, Beiner JM, Hillibrand A, Albert TJ, Anderson DG, Vaccaro AR: Osteogenic potential of adult human stem cells of the lumbar vertebral body and the iliac crest. Spine 31:83-89, 2006.
75. Robertson PA, Wray AC: Natural history of posterior iliac crest bone graft donation for spinal surgery: A prospective analysis of morbidity. Spine 26:1473-1476, 2001.
76. Robinson Y, Heyde CE, Tschöke SK, Mont MA, Seyler TM, Ulrich SD: Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgery. Expert Rev Med Devices 5:75-84, 2008.
77. Sandhu HS, Boden SD, An H, Kang J, Weinstein J: BMPs and gene therapy for spinal fusion: Summary statement. Spine 28:S85, 2003.
78. Sanfilippo JA Jr, Lee JY, Rihn J, Albert TJ, Hilibrand A: BMP-2 causes increased postoperative radiculitis following TLIF. Spine J 7:5S-6S, 2007.
79. Sasso RC, LeHuec JC, Shaffrey C; Spine Interbody Research Group: Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: A prospective patient satisfaction outcome assessment. J Spinal Disord Tech 18 [Suppl]: S77-S81, 2005.
80. Sawin PD, Traynelis VC, Menezes AH: A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. J Neurosurg 88:255-265, 1998.
81. Shen FH, Samartzis D, An HS: Cell technologies for spinal fusion. Spine J 5:231S-239S, 2005.
82. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB: Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31:542-547, 2006.
83. Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland JM, Hilibrand AS, Vaccaro AR, Albert TJ: Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 28:134-139, 2003.
84. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG: Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31:2813-2819, 2006.
85. Vaccaro AR, Chiba K, Heller JG, Patel TCh, Thalgott JS, Truumees E, Fischgrund JS, Craig MR, Berta SC, Wang JC; North American Spine Society for Contemporary Concepts in Spine Care: Bone grafting alternatives in spinal surgery. Spine J 2:206-215, 2002.
86. Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM: Complications of anterior cervical discectomy and fusion using recombinant human bone mor-phogenetic protein-2. Eur Spine J 16:1257-1265, 2007.
87. Vaidya R, Weir R, Sethi A, Meisterling S, Hakeos W, Wybo CD: Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J Bone Joint Surg Br 89B:342-345, 2007.
88. Viggeswarapu M, Boden SD, Liu Y, Hair GA, Louis-Ugbo J, Murakami H, Kim HS, Mayr MT, Hutton WC, Titus L: Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am 83A:364-376, 2001.
89. Wang T, Dang G, Guo Z, Yang M: Evaluation of autologous bone marrow mesenchymal stem cell-calcium phosphate ceramic composite for lumbar fusion in rhesus monkey interbody fusion model. Tissue Eng 11:1159-1167, 2005.
90. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman JR: Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am 85A:905-911, 2003.
91. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K: Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J EPub 11/26/2007.
92. Yoon ST, Boden SD: Spine fusion by gene therapy. Gene Ther 11:360-367, 2004.
93. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C: Combined bone morphogenetic pro-tein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 19:2021-2032, 2004.